Originally published in Lawfare.
Matthew Schwartz, founder of Virgo, joins Kevin Frazier, the AI Innovation and Law Fellow at the University of Texas School of Law and a Senior Editor at Lawfare, to discuss how AI is beginning to reshape gastroenterology. Virgo’s model is trained on one of the largest collections of endoscopy procedure videos ever assembled, opening new possibilities for earlier diagnosis, personalized treatment of diseases like inflammatory bowel disease, and faster clinical research.
The duo also examine how medical imaging data can generate new “digital biomarkers,” what role AI might play in shortening clinical trials, and how regulators and healthcare institutions are grappling with the promise—and risks—of deploying AI in clinical environments.